← Dashboard
Stock
OSCR
Oscar Health, Inc.Latest close $226 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
6
27 funds tracked
Ever held
15
Current + past
New this quarter
0
Exited this quarter
1
Marquee-fund ownership over time
May 14, 2021May 15, 2024Aug 14, 2025May 14, 2026
Now
6
This quarter's activity
New positions opened
None.
Positions exited
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $18 | $22 | +20% |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $18 | $22 | +20% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $18 | $22 | +20% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $18 | $22 | +20% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $18 | $22 | +20% |
| Point72 Asset Management re-entered | Q3 2024(8Q snapshot) | 7Q | $18 | $22 | +20% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Renaissance Technologies 2× in & out | Q1 2026 | Q2 2026 | → $23 | +69% |
| Glenview Capital 2× in & out | Q4 2025 | Q1 2026 | → $13 | -4% |
| Soros Fund Management 2× in & out | Q4 2025 | Q1 2026 | → $13 | -3% |
| Maverick Capital | Q3 2025 | Q4 2025 | → $14 | -5% |
| Viking Global Investors | Q2 2024 | Q2 2025 | → $17 | -27% |
| Scion Asset Management | Q1 2025 | Q2 2025 | → $17 | +23% |
| Duquesne Family Office | Q4 2021 | Q2 2023 | → $7.18 | -41% |
| Tiger Global | Q2 2021 | Q3 2022 | → $7.95 | -66% |
| Coatue Management | Q2 2021 | Q2 2022 | → $5.85 | -74% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Oscar Health, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
Filings · last 30d
12
Filings · last 90d
18
Total on file
264
Recent SEC buffer
Most recent
Jun 8, 2026
30d / 90d windows measured from Jun 8, 2026 — the most recent Form 4 on file — not from today.
- Form 40001568651-26-000057Jun 8, 2026
- Form 40001844229-26-000007Jun 8, 2026
- Form 40001509066-26-000004Jun 8, 2026
- Form 40001954883-26-000009Jun 8, 2026
- Form 40001229265-26-000016Jun 8, 2026
- Form 40001911946-26-000004Jun 4, 2026
- Form 40001844320-26-000009Jun 4, 2026
- Form 40001842979-26-000003Jun 4, 2026
- Form 40001888381-26-000004Jun 4, 2026
- Form 40001525020-26-000011Jun 4, 2026
- Form 40001525020-26-000009May 20, 2026
- Form 40001525020-26-000007May 18, 2026
- Form 40001509066-26-000002Apr 13, 2026
- Form 40001954883-26-000007Apr 13, 2026
- Form 40001214606-26-000006Apr 13, 2026
Showing 15 of 264 recent Form 4 filings. Browse all on EDGAR ↗
Fundamentals
XBRL · Oscar Health, Inc.Annual figures sourced directly from Oscar Health, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Revenue
$11.7B
FY2025+28% YoY
Net income
-$443.15M
FY2025-500%+ YoY
EPS (diluted)
$-1.69
FY2025-500%+ YoY
Free cash flow(?)
$1.09B
FY2025+12% YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Oscar Health, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventJun 9, 2026
- 8-KMaterial eventJun 8, 2026
- 8-KMaterial eventJun 2, 2026
- 10-QQuarterly reportMay 7, 2026
- 8-KMaterial eventMay 6, 2026
- DEF 14AProxy statementApr 22, 2026
- 8-KMaterial eventApr 21, 2026
- 8-KMaterial eventMar 2, 2026
- 10-KAnnual reportFeb 13, 2026
- 8-KMaterial eventFeb 10, 2026
- 8-KMaterial eventDec 29, 2025
- 10-QQuarterly reportNov 6, 2025
- 8-KMaterial eventNov 6, 2025
- 8-KMaterial eventSep 18, 2025
- 8-KMaterial eventSep 16, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Renaissance Technologies | Q1 2026 | Q2 2026 | $14 | $23 | +69% |
| Soros Fund Management | Q4 2025 | Q1 2026 | $14 | $13 | -3% |
| Glenview Capital | Q4 2025 | Q1 2026 | $14 | $13 | -4% |
| Point72 Asset Management | Q4 2025 | open | $14 | $25 | +82% |
| Maverick Capital | Q3 2025 | Q4 2025 | $15 | $14 | -5% |
| Glenview Capital | Q2 2025 | Q3 2025 | $17 | $15 | -11% |
| Scion Asset Management | Q1 2025 | Q2 2025 | $13 | $17 | +23% |
| Soros Fund Management | Q4 2024 | Q1 2025 | $15 | $13 | -13% |
| Citadel Advisors | Q3 2024 | open | $18 | $25 | +39% |
| Two Sigma Investments | Q3 2024 | open | $18 | $25 | +39% |
| D.E. Shaw | Q3 2024 | open | $18 | $25 | +39% |
| AQR Capital Management | Q3 2024 | open | $18 | $25 | +39% |
| Millennium Management | Q3 2024 | open | $18 | $25 | +39% |
| Point72 Asset Management | Q3 2024 | Q1 2025 | $18 | $13 | -26% |
| Renaissance Technologies | Q3 2024 | Q4 2025 | $18 | $14 | -23% |
| Viking Global Investors | Q2 2024 | Q2 2025 | $23 | $17 | -27% |
| Duquesne Family Office | Q4 2021 | Q2 2023 | $12 | $7.18 | -41% |
| Tiger Global | Q2 2021 | Q3 2022 | $24 | $7.95 | -66% |
| Coatue Management | Q2 2021 | Q2 2022 | $23 | $5.85 | -74% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.